PositiveID Corp. (PSID) Expanding Their Biological Detection Capabilities
On Wednesday, PositiveID Corp. announced that the Company is expanding their biological detection capabilities to include the detection of H5N1, or avian flu. This is amid signs that a mutant strain of the deadly bird flu virus is spreading overseas. Via their MicroFluidic Systems (MFS) subsidiary, PositiveID has the biological capability to detect virtually any virus, bacteria, or toxin in an environmental or clinical environment. The Company is completing a test to identify, cost-effectively and quickly, the mutant strain of H5N1. They expect to have their laboratory development completed in the fourth quarter of this year. PositiveID has created and…